CRYSTAL JONES: Open Payments
NPI 1619462066 · MIDDLESBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 7 companies in 2025. Trend: 2023 $110 · 2024 $169 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $71 |
| ABBVIE INC. | 3 | $52 |
| Novo Nordisk Inc | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Phadia US Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Verona Pharma, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, VRAYLAR, CAPLYTA, Ozempic, ImmunoCAP, MOUNJARO, Ohtuvayre, Rybelsus.
Industry payments across KY — which companies pay providers there.
